{
  "meta": {
    "source": "Term 7 - Endocrine",
    "lesson": "Diabetes"
  },
  "questions": [
    {
      "id": 7650,
      "question": "A 24-year-old woman with Type 1 diabetes (6 years) on insulin asks about congenital malformation risk. What is the relative risk in infants of diabetic mothers compared with non-diabetics?",
      "options": [
        "No increased risk",
        "2-4 fold increased risk",
        "8-10 fold",
        "6-8 fold",
        "> 10-fold increased risk"
      ],
      "correct_option_id": 1,
      "explanation": "Maternal diabetes with suboptimal control during organogenesis increases the risk of congenital malformations (e.g., cardiac, neural tube) by 2-4 fold compared to the general population.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pregnancy & Diabetes"
    },
    {
      "id": 7651,
      "question": "A 30-year-old man with insulin-dependent diabetes and hypothyroidism develops fatigue, weight loss, and increasing pigmentation of the skin and buccal mucosa. The most likely cause of the recent complaint is:",
      "options": [
        "Vitiligo.",
        "Pan hypopituitarism.",
        "Addison's disease.",
        "Celiac disease.",
        "Peutz-jeghers syndrome."
      ],
      "correct_option_id": 2,
      "explanation": "This indicates Schmidt's Syndrome (APS Type 2): T1DM, Thyroid disease, and Addison's. Adrenal insufficiency increases ACTH, causing hyperpigmentation, fatigue, and weight loss.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Comorbidities"
    },
    {
      "id": 7652,
      "question": "A 46-year-old male presents to the clinic. He complains of excessive flatulence following starting a new agent for management of his type II diabetes mellitus. He has no other past medical history. What drug is most likely implicated:",
      "options": [
        "Glibenclamide",
        "Gliclazide",
        "Acarbose",
        "Sitagliptin",
        "Empagliflozin"
      ],
      "correct_option_id": 2,
      "explanation": "Acarbose inhibits alpha-glucosidase, reducing gut carbohydrate absorption. Fermentation of undigested carbs by colonic bacteria causes significant flatulence.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    },
    {
      "id": 7653,
      "question": "Acanthosis nigricans is skin lesion may be associated with:",
      "options": [
        "Hypoparathyroidism",
        "Insulin resistance",
        "Hypercholesterolemia",
        "Microadenoma of pituitary",
        "Hyperprolactinemia"
      ],
      "correct_option_id": 1,
      "explanation": "Acanthosis nigricans presents as dark, velvety skin markings in body folds. It is strongly associated with states of insulin resistance, such as Type 2 Diabetes and Obesity.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Clinical Features"
    },
    {
      "id": 7654,
      "question": "All of the following are risk factors for type 2 diabetes mellitus EXCEPT:",
      "options": [
        "BMI above 25 kg/m2",
        "Delivery of a baby more than 3.5 kg",
        "HDL level below 35 mg/dl.",
        "Hemoglobin A1c 5.7-6.4%",
        "Systemic hypertension"
      ],
      "correct_option_id": 1,
      "explanation": "Risk factors include gestational diabetes or macrosomia (>4kg). A 3.5kg birth weight is normal. High BMI, low HDL, and hypertension are established risk factors.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Risk Factors"
    },
    {
      "id": 7655,
      "question": "All typical features of central DI EXCEPT:",
      "options": [
        "Specific gravity less than 1005 with decrease urine osmolality and increase plasma osmolality.",
        "Onset following basal meningitis & hypothalamic trauma.",
        "Decrease renal responsiveness to ADH."
      ],
      "correct_option_id": 2,
      "explanation": "Decreased renal responsiveness to ADH is the definition of Nephrogenic Diabetes Insipidus, not Central DI. Central DI is caused by a failure of ADH secretion (pituitary/hypothalamic pathology).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diabetes Insipidus"
    },
    {
      "id": 7656,
      "question": "Autoimmune destruction of pancreatic \u03b2 cells is the pathogenic factor in development of:",
      "options": [
        "Type I DM",
        "Type II DM",
        "Gestational DM",
        "Bronzed DM",
        "Secondary DM"
      ],
      "correct_option_id": 0,
      "explanation": "Type 1 Diabetes Mellitus results from a T-cell mediated autoimmune destruction of the insulin-secreting beta cells in the pancreas, leading to absolute insulin deficiency.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pathophysiology"
    },
    {
      "id": 7657,
      "question": "Causes of DI include all of the following EXCEPT:",
      "options": [
        "Craniopharyngioma.",
        "Sarcoidosis.",
        "Sever hypocalcemia.",
        "Sever increase in Ca & decrease in K."
      ],
      "correct_option_id": 2,
      "explanation": "Severe hypercalcemia and hypokalemia can cause Nephrogenic Diabetes Insipidus. However, hypocalcemia (low calcium) does not cause DI and is the correct exception.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diabetes Insipidus"
    },
    {
      "id": 7658,
      "question": "Causes of nephrogenic DI include all of the following EXCEPT:",
      "options": [
        "Lithium therapy.",
        "Heavy metal poisoning.",
        "Demeclocycline.",
        "Cloropropamide."
      ],
      "correct_option_id": 3,
      "explanation": "Lithium, heavy metals, and Demeclocycline cause Nephrogenic DI. Chlorpropamide treats partial Central DI by potentiating ADH action.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diabetes Insipidus"
    },
    {
      "id": 7659,
      "question": "Clinical picture of diabetes insipidus include:",
      "options": [
        "Polyuria.",
        "Galactorrhea.",
        "Polyphagia.",
        "Polydipsia."
      ],
      "correct_option_id": 0,
      "explanation": "The hallmark of Diabetes Insipidus is polyuria (large dilute urine volume), leading to secondary polydipsia (thirst). Polyphagia is a symptom of Diabetes Mellitus.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diabetes Insipidus"
    },
    {
      "id": 7660,
      "question": "Clinical picture of type I diabetes mellitus include all EXCEPT:",
      "options": [
        "Polyuria & polydipsia.",
        "Loss of weight.",
        "Increased susceptibility to infection.",
        "Morning stiffness."
      ],
      "correct_option_id": 3,
      "explanation": "Classical Type 1 DM symptoms are polyuria, polydipsia, and weight loss. Morning stiffness is typical of inflammatory arthritis, not diabetes.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Clinical Features"
    },
    {
      "id": 7661,
      "question": "Complications of diabetes mellitus include:",
      "options": [
        "Lipohypertrophy.",
        "Photosensitivity with oral hypoglycaemic agents.",
        "An isolated cranial nerve palsy.",
        "Necrobiosis lipoidica diabeticorum.",
        "All of the above"
      ],
      "correct_option_id": 4,
      "explanation": "Complications include lipohypertrophy, drug-induced photosensitivity, mononeuropathies, and necrobiosis lipoidica. All listed options are recognized associations.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Complications"
    },
    {
      "id": 7662,
      "question": "Diabetic ketoacidosis caused by:",
      "options": [
        "Insulin deficiency.",
        "Glucagon colitis.",
        "Both."
      ],
      "correct_option_id": 0,
      "explanation": "DKA is primarily driven by absolute or relative insulin deficiency. (Note: Option 'b' likely refers to 'Glucagon excess', but the answer key selects 'Insulin deficiency' as the primary driver here).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Acute Complications"
    },
    {
      "id": 7663,
      "question": "Diabetic ketoacidosis is caused by:",
      "options": [
        "Insulin deficiency.",
        "Glucagon excess.",
        "Both."
      ],
      "correct_option_id": 2,
      "explanation": "The pathophysiology of DKA involves both severe insulin deficiency and an excess of counter-regulatory hormones, particularly glucagon, which drives ketogenesis and gluconeogenesis.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Acute Complications"
    },
    {
      "id": 7664,
      "question": "Diabetic ketoacidosis is characterized by:",
      "options": [
        "Rapid respiration.",
        "Dehydration.",
        "Rapid small pulse.",
        "All of the above."
      ],
      "correct_option_id": 3,
      "explanation": "DKA presents with Kussmaul respirations (rapid, deep breathing to compensate for acidosis), profound dehydration due to osmotic diuresis, and tachycardia (rapid pulse) as a sign of volume depletion.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Acute Complications"
    },
    {
      "id": 7665,
      "question": "Diabetic ketoacidosis is treated by:",
      "options": [
        "IV fluid.",
        "K.",
        "Both."
      ],
      "correct_option_id": 2,
      "explanation": "Management of DKA rests on three pillars: Intravenous fluids for resuscitation, Insulin to stop ketogenesis, and Electrolyte replacement (especially Potassium, as insulin shifts K+ into cells).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7666,
      "question": "Diabetic nephropathy not associated with:",
      "options": [
        "Hypotension",
        "Anaemia.",
        "Retinopathy.",
        "Cardiovascular disease.",
        "Nephrotic syndrome."
      ],
      "correct_option_id": 0,
      "explanation": "Diabetic nephropathy is associated with hypertension (accelerates damage), anemia (low EPO), retinopathy, and cardiovascular disease. Hypotension is not a typical feature.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Chronic Complications"
    },
    {
      "id": 7667,
      "question": "Diagnostic Criteria for Diabetes Mellitus include the following EXCEPT:",
      "options": [
        "Fasting plasma glucose> 126 (mg/dL)",
        "Oral glucose tolerance test\u2265 200 (mg/dL)",
        "Glycosylated hemoglobin\u2265 6.5 (HbA1c [%])",
        "C-peptide level 5.7 (mg/dL)",
        "Random blood glucose level\u2265 200 (mg/dL) + classic symptoms"
      ],
      "correct_option_id": 3,
      "explanation": "Standard criteria: FPG \u2265 126, OGTT \u2265 200, HbA1c \u2265 6.5%, or Random \u2265 200 with symptoms. C-peptide distinguishes type but is not diagnostic for DM itself.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diagnosis"
    },
    {
      "id": 7668,
      "question": "Drugs that mimicking the prandial and post-prandial release of insulin:",
      "options": [
        "Sulfonylureas.",
        "Incretin inhibitors.",
        "Meglitinide analogues.",
        "Thiazolidine diones.",
        "Metformin."
      ],
      "correct_option_id": 2,
      "explanation": "Meglitinide analogues (e.g., Repaglinide) are short-acting insulin secretagogues designed to stimulate rapid insulin release, mimicking the physiological prandial surge.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    },
    {
      "id": 7669,
      "question": "Gluconeogenesis is a process of generation of glucose from non-glucose sources such as amino-acids, glycerol, fatty acids, and lactate. Which one of the following organs participates in the process of gluconeogenesis in human beings:",
      "options": [
        "Liver and adipose tissue",
        "Liver and kidney",
        "Liver and pancreas",
        "Pancreas and adipose tissue",
        "Pancreas and muscles"
      ],
      "correct_option_id": 1,
      "explanation": "The liver is the main site. The kidney cortex also has enzymes like glucose-6-phosphatase and contributes to gluconeogenesis, especially during prolonged starvation.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pathophysiology"
    },
    {
      "id": 7670,
      "question": "HbA1c assess blood glucose in previous 3 months while glycated albumin assess:",
      "options": [
        "Previous 2 months",
        "Previous 2 weeks",
        "Previous 2 days",
        "Previous 2 hours",
        "Previous 12 hours"
      ],
      "correct_option_id": 1,
      "explanation": "HbA1c reflects glucose control over the lifespan of red blood cells (approx. 3 months). Glycated albumin reflects the half-life of serum albumin, which is about 2 to 3 weeks.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diagnosis"
    },
    {
      "id": 7671,
      "question": "Hypertriglyceridemia is the common pattern of dyslipidemia in diabetes; it is a risk factor for:",
      "options": [
        "Atherosclerosis",
        "IHD ischemic heart disease",
        "Stroke",
        "Acute pancreatitis",
        "Porphyria"
      ],
      "correct_option_id": 3,
      "explanation": "Severe hypertriglyceridemia (often seen in uncontrolled diabetes) is a direct and well-known cause of acute pancreatitis.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Complications"
    },
    {
      "id": 7672,
      "question": "Immune mediated DM is present in:",
      "options": [
        "Type I.",
        "Type 2.",
        "Both."
      ],
      "correct_option_id": 0,
      "explanation": "Immune-mediated diabetes refers specifically to Type 1 DM (Type 1A), where autoantibodies destroy pancreatic beta cells.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pathophysiology"
    },
    {
      "id": 7673,
      "question": "In diabetic ketoacidosis treatment is by the following EXCEPT:",
      "options": [
        "K.",
        "Oral hypoglycemic.",
        "IV fluid."
      ],
      "correct_option_id": 1,
      "explanation": "Oral hypoglycemic agents have no role in the acute management of DKA. Treatment strictly requires IV fluids, IV insulin, and electrolyte correction (potassium).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7674,
      "question": "In diabetic ketoacidosis; one is false:",
      "options": [
        "Hypotonic saline is the fluid replacement most often indicated.",
        "Large volumes of fluid may be needed.",
        "Precipitating episode may be a urinary tract infection.",
        "Abdominal pain may be a prominent symptom.",
        "Potassium supplementation is required."
      ],
      "correct_option_id": 0,
      "explanation": "Isotonic saline (0.9% NaCl) is the initial fluid for DKA resuscitation to restore volume. Hypotonic saline is not the standard starting fluid.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7675,
      "question": "In the very early stage of diabetic nephropathy there is:",
      "options": [
        "Increase GFR.",
        "Urea and creatinine.",
        "Proteinuria."
      ],
      "correct_option_id": 0,
      "explanation": "The initial functional change in diabetic nephropathy is glomerular hyperfiltration, leading to an increased GFR. This precedes microalbuminuria and the eventual decline in renal function.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Chronic Complications"
    },
    {
      "id": 7676,
      "question": "In type 2 DM, preferred drug for blood pressure control is:",
      "options": [
        "Calcium channel blockers",
        "Alpha blockers",
        "Beta blockers",
        "ACE inhibitors",
        "Vasodilators"
      ],
      "correct_option_id": 3,
      "explanation": "ACE inhibitors (and ARBs) are the preferred antihypertensives in diabetics because they provide renoprotection by reducing intraglomerular pressure and slowing the progression of nephropathy.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7677,
      "question": "In type II diabetes mellitus insulin resistance is increased by:",
      "options": [
        "Exercise.",
        "Obesity.",
        "Metformin."
      ],
      "correct_option_id": 1,
      "explanation": "Obesity (visceral adiposity) increases free fatty acids and inflammation, worsening insulin resistance. Exercise and metformin improve sensitivity.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pathophysiology"
    },
    {
      "id": 7678,
      "question": "Insulin induced hypoglycemia all are true EXCEPT:",
      "options": [
        "Best terminated as soon as 9 mm.",
        "Sever hypoglycemic symptoms.",
        "Contra indicated in IND & epilepsy.",
        "Contra indicated in severe hypopituitarism.",
        "Test hypothalamic pituitary tract mandatory to confirm diagnosis."
      ],
      "correct_option_id": 2,
      "explanation": "The Insulin Tolerance Test assesses pituitary function but is hazardous. It is contraindicated in epilepsy and ischemic heart disease due to stress and seizure risk.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Acute Complications"
    },
    {
      "id": 7679,
      "question": "Islet \u03b2-cells secrete:",
      "options": [
        "Somatostatin",
        "C-peptide",
        "Glucagon",
        "Pancreatic lipase",
        "Melanocyte stimulating hormone"
      ],
      "correct_option_id": 1,
      "explanation": "Pancreatic Beta cells secrete insulin and C-peptide in equimolar amounts (as byproducts of proinsulin cleavage). Alpha cells secrete glucagon, and Delta cells secrete somatostatin.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Physiology"
    },
    {
      "id": 7680,
      "question": "Metformin is widely used in diabetes, in addition to its hypoglycemic effect can be used for:",
      "options": [
        "Losing weight",
        "Insulin blocker",
        "Stimulate appetite",
        "Stimulate hepatic glucose production",
        "Diabetes insipidus"
      ],
      "correct_option_id": 0,
      "explanation": "Metformin is weight-neutral or can cause modest weight loss, making it particularly useful in obese Type 2 diabetics. It decreases hepatic glucose production rather than stimulating it.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    },
    {
      "id": 7681,
      "question": "New drug in treatment of diabetes mellitus is:",
      "options": [
        "Acarbose.",
        "Metformin.",
        "Gliclazide."
      ],
      "correct_option_id": 0,
      "explanation": "Compared to older sulfonylureas and biguanides, Acarbose is considered newer in historical context, though SGLT2/GLP-1 agents are now current.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    },
    {
      "id": 7682,
      "question": "Obese, diabetic female (5 years duration) On maximum dose of an oral hypoglycemic drug. Recently her blood sugar is badly controlled (200 mg fasting - 390 mg P.P) with drugs. The best management is:",
      "options": [
        "Change to insulin therapy all through.",
        "Combination of different types of oral hypoglycemic drugs"
      ],
      "correct_option_id": 1,
      "explanation": "For an obese patient failing monotherapy, adding a second oral agent is preferred to avoid insulin-induced weight gain.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7683,
      "question": "One of the following does not cause diabetes insipidus:",
      "options": [
        "DIDMOAD syndrome",
        "Severe hypocalcemia",
        "Craniopharyngioma",
        "Sarcoidosis",
        "Cranial radiotherapy"
      ],
      "correct_option_id": 1,
      "explanation": "Severe hypercalcemia (high calcium) can cause nephrogenic DI. Hypocalcemia (low calcium) is not a cause. DIDMOAD, Craniopharyngioma, Sarcoidosis, and Radiotherapy can cause central DI.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diabetes Insipidus"
    },
    {
      "id": 7684,
      "question": "One of the following is not true about diabetes insipidus:",
      "options": [
        "Daily urine volume is >50 mL/kg body weight",
        "Urine osmolarity is <300 mosmol/L",
        "Dehydration is common",
        "Enuresis is common",
        "May be central or peripheral"
      ],
      "correct_option_id": 3,
      "explanation": "Classic DI features are polyuria and polydipsia. While enuresis can occur, it is less defining than the rigorous physiological criteria of volume and osmolarity.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diabetes Insipidus"
    },
    {
      "id": 7685,
      "question": "Polyuria (Polydipsia) dehydration may be due:",
      "options": [
        "Diabetes mellitus.",
        "Diabetes insipidus.",
        "Severe Hypercalcemia.",
        "All of the above.",
        "None of the above."
      ],
      "correct_option_id": 3,
      "explanation": "Polyuria and polydipsia are shared symptoms of DM (osmotic diuresis from glucose), DI (lack of ADH effect), and severe Hypercalcemia (which causes nephrogenic DI).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Differential Diagnosis"
    },
    {
      "id": 7686,
      "question": "Prediabetes is characterized by:",
      "options": [
        "FBS (100-125mg/dl) 2-h PG (140-199mg/dl) HbA1c (5.3%-6%)",
        "FBS (110-126mg/dl) 2-h PG (140-199mg/dl) HbA1c (5.7%-6%)",
        "FBS (100-125mg/dl) 2-h PG (140-199 mg/dl) HbA1c (5.7%-6.4%)",
        "FBS (>125mg/dl) 2-h PG (120-140 mg/dl) HbA1c (5.3%-6.7%)",
        "FBS (100-125mg/dl) 2-h PG (110-140mg/dl) HbA1c (5.7%-6.4%)"
      ],
      "correct_option_id": 2,
      "explanation": "Standard Prediabetes criteria are: Fasting Glucose 100-125 mg/dL, 2-hour Post-prandial 140-199 mg/dL, and HbA1c 5.7% - 6.4%.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diagnosis"
    },
    {
      "id": 7687,
      "question": "Secondary diabetes may be caused by the following EXCEPT:",
      "options": [
        "Acute pancreatitis.",
        "Insulinoma.",
        "Glucagonoma."
      ],
      "correct_option_id": 1,
      "explanation": "Insulinoma is an insulin-secreting tumor leading to hypoglycemia. It does not cause Diabetes (which is hyperglycemia). Pancreatitis and Glucagonoma can cause secondary diabetes.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Secondary Diabetes"
    },
    {
      "id": 7688,
      "question": "The best treatment of type I diabetes Mellitus is:",
      "options": [
        "Oral hypoglycemic drugs.",
        "Insulin.",
        "Low caloric diet."
      ],
      "correct_option_id": 1,
      "explanation": "Type 1 DM is characterized by absolute insulin deficiency. The only effective treatment is exogenous insulin replacement. Oral hypoglycemic drugs are generally ineffective.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7689,
      "question": "The criteria for the diagnosis of DKA include the following EXCEPT:",
      "options": [
        "Hyperglycemia (blood glucose >200 mg/dl)",
        "Serum bicarbonate <15 mmol/ (metabolic acidosis).",
        "Ketonemia or ketonuria.",
        "Venous pH <7.3",
        "Coma"
      ],
      "correct_option_id": 4,
      "explanation": "The diagnostic triad for DKA is Hyperglycemia, Ketosis, and Acidosis (pH <7.3, Bicarb <15). Coma is a clinical sign of severity but is not required for diagnosis (most patients are conscious).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Acute Complications"
    },
    {
      "id": 7690,
      "question": "The drug of choice In severe ketoacidosis is:",
      "options": [
        "Glibenclamide",
        "NPH insulin",
        "Soluble (regular) insulin",
        "Ultralent insulin",
        "Long-acting insulin."
      ],
      "correct_option_id": 2,
      "explanation": "Short-acting Soluble (Regular) Insulin is the drug of choice for DKA because it can be administered intravenously for rapid effect and precise titration.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7691,
      "question": "The first line of therapy of DKA is:",
      "options": [
        "Insulin",
        "Sodium bicarbonate",
        "IV fluids",
        "Potassium therapy",
        "Antibiotics"
      ],
      "correct_option_id": 2,
      "explanation": "Immediate volume resuscitation with IV fluids is the first and most critical step in DKA management to restore tissue perfusion and help clear glucose and ketones renally.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7692,
      "question": "The following clinical feature of diabetes insipidus is false:",
      "options": [
        "Daily urine volume is >50 mL/kg body weight-",
        "Urine osmolarity is <300 mosmol/L",
        "Dehydration is common",
        "Enuresis is common",
        "Polydipsia"
      ],
      "correct_option_id": 3,
      "explanation": "Classic features are polyuria (dilute urine) and polydipsia. Enuresis is not as defining or universal a feature as the physiological signs.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diabetes Insipidus"
    },
    {
      "id": 7693,
      "question": "The initial treatment of obese type II diabetes mellitus is:",
      "options": [
        "Sulfonylureas.",
        "biguanides.",
        "Weight reduction."
      ],
      "correct_option_id": 2,
      "explanation": "Lifestyle modifications, specifically diet and weight reduction, are the first-line intervention for obese Type 2 diabetics before pharmacotherapy is initiated.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7694,
      "question": "The insulin that can be administered intravenously is:",
      "options": [
        "Soluble (regular) insulin",
        "Isophane (NPH) insulin",
        "Lente insuline",
        "Semilent insuline",
        "Long-acting insulin"
      ],
      "correct_option_id": 0,
      "explanation": "Soluble (Regular) insulin is the only traditional formulation clear and safe for intravenous use. Cloudy suspensions like NPH and Lente must never be given IV.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    },
    {
      "id": 7695,
      "question": "The main route of administration of insulin is:",
      "options": [
        "Intravenous",
        "Subcutanoues.",
        "Intramuscular.",
        "Orally",
        "Sublingual"
      ],
      "correct_option_id": 1,
      "explanation": "Subcutaneous injection is the standard route for routine daily insulin administration. IV is reserved for emergencies like DKA.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7696,
      "question": "The most serious short-term complication of diabetes is:",
      "options": [
        "Retinopathy.",
        "Nephropathy",
        "Hypoglycemia",
        "Heart disease",
        "Neuropathy"
      ],
      "correct_option_id": 2,
      "explanation": "Hypoglycemia (especially if severe) is the most dangerous short-term complication because it can rapidly lead to loss of consciousness, seizures, brain damage, and death if untreated.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Acute Complications"
    },
    {
      "id": 7697,
      "question": "Type II diabetes mellitus is associated with:",
      "options": [
        "Insulin resistance.",
        "Cell defect.",
        "Both."
      ],
      "correct_option_id": 2,
      "explanation": "Type 2 DM is caused by a combination of peripheral insulin resistance (decreased sensitivity) and beta-cell dysfunction (inability to secrete enough insulin to overcome resistance).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pathophysiology"
    },
    {
      "id": 7698,
      "question": "Type II DM may need (may be treated with):",
      "options": [
        "Oral hypoglycemic.",
        "Insulin.",
        "Both."
      ],
      "correct_option_id": 2,
      "explanation": "Type 2 DM is a progressive disease. Patients may start on oral hypoglycemic agents but may eventually require insulin (alone or in combination) as beta-cell function declines.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7699,
      "question": "Type of diabetes mellitus resulting from autoimmune beta cell destruction is:",
      "options": [
        "Type 2",
        "MODy 1",
        "Type 1",
        "MODY 2",
        "In association with PCO"
      ],
      "correct_option_id": 2,
      "explanation": "Type 1 Diabetes Mellitus is defined by the autoimmune destruction of pancreatic beta cells, confirmed by the presence of autoantibodies (e.g., GAD65, IA-2).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pathophysiology"
    },
    {
      "id": 7700,
      "question": "Type of insulin which can be given IV is:",
      "options": [
        "Regular soluble insulin",
        "Isoplane",
        "Lente",
        "Semilente",
        "Insulin glargine"
      ],
      "correct_option_id": 0,
      "explanation": "Regular (Soluble) insulin is the specific formulation used for intravenous infusion. Long-acting analogs like Glargine or suspensions like Lente cannot be given IV.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    },
    {
      "id": 7701,
      "question": "When ---------------- is combined with Insulin severe edema occurs.",
      "options": [
        "Rosiglitazone.",
        "Pioglitazone.",
        "Metformin.",
        "Tolbutamide.",
        "Tolbutamid"
      ],
      "correct_option_id": 0,
      "explanation": "Thiazolidinediones (Rosiglitazone) cause fluid retention. Combined with insulin, this synergistically increases the risk of severe edema and heart failure.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    },
    {
      "id": 7702,
      "question": "Which of the following clinical features of diabetes insipidus is false?",
      "options": [
        "Daily urine volume is >50 mL/kg body weight",
        "Urine osmolarity is <300 mosmol/L",
        "Dehydration is common",
        "Enuresis is common",
        "Polydipsia"
      ],
      "correct_option_id": 3,
      "explanation": "While bedwetting can happen, it is not considered as cardinal or universal a feature as polyuria (dilute urine), polydipsia (thirst), and susceptibility to dehydration.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Diabetes Insipidus"
    },
    {
      "id": 7703,
      "question": "Which one of the following processes is responsible for ketone production during diabetic ketoacidosis?",
      "options": [
        "Glycogenolysis",
        "Exchange with hydrogen ions in the collecting ducts",
        "Gluconeogenesis",
        "Decreased plasma bicarbonate levels",
        "Lipolysis"
      ],
      "correct_option_id": 4,
      "explanation": "In the absence of insulin, unrestrained lipolysis occurs in adipose tissue. This releases large amounts of free fatty acids, which travel to the liver and are converted into ketone bodies.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pathophysiology"
    },
    {
      "id": 7704,
      "question": "Which one preparation of insulin can be given intravenously?",
      "options": [
        "Insuline glargine",
        "Humiline Lent.",
        "NPH insulin",
        "Humuline regular",
        "Insulin Lispro."
      ],
      "correct_option_id": 3,
      "explanation": "Humulin Regular (Soluble) is the formulation approved for IV use in conditions like DKA.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    },
    {
      "id": 7705,
      "question": "Which one preparation of insulin can be used in case of Ketoacidosis?",
      "options": [
        "Insulin aspart.",
        "Insulin lispro.",
        "Humaline regular.",
        "All of the above",
        "None of the above."
      ],
      "correct_option_id": 3,
      "explanation": "Regular insulin is traditional for IV use. Rapid-acting analogs (Aspart, Lispro) are also effective IV. Thus, 'All of the above' is correct.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Management"
    },
    {
      "id": 7706,
      "question": "Which type of hypoglycemia would an insulinoma cause?",
      "options": [
        "Reactive.",
        "Drug-induced.",
        "Alimentary.",
        "Fasting."
      ],
      "correct_option_id": 3,
      "explanation": "Insulinomas secrete insulin independently of blood glucose levels. This typically leads to hypoglycemia during periods of fasting (fasting hypoglycemia), usually relieved by eating (Whipple's triad).",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Complications"
    },
    {
      "id": 7707,
      "question": "A 55-year-old woman with recurrent UTIs (three in three months) has Type 2 diabetes and started antidiabetic therapy four months ago. Which drug is most likely responsible?",
      "options": [
        "Acarbose",
        "Dapagliflozin",
        "Gliclazide",
        "Vildagliptin",
        "Metformin"
      ],
      "correct_option_id": 1,
      "explanation": "Dapagliflozin (SGLT2 inhibitor) induces glucosuria. Sugar in urine promotes bacterial and fungal growth, leading to recurrent UTIs and thrush.",
      "term": "Term 7",
      "subject": "Endocrine",
      "lesson": "Diabetes",
      "chapter": "Pharmacology"
    }
  ]
}